[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1193 Introduced in House (IH)]
<DOC>
117th CONGRESS
1st Session
H. R. 1193
To amend title IV of the Public Health Service Act to direct the
Director of the National Institutes of Health, in consultation with the
Director of the National Heart, Lung, and Blood Institute, shall
establish a program under which the Director of the National Institutes
of Health shall support or conduct research on valvular heart disease,
and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 22, 2021
Mr. Barr introduced the following bill; which was referred to the
Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend title IV of the Public Health Service Act to direct the
Director of the National Institutes of Health, in consultation with the
Director of the National Heart, Lung, and Blood Institute, shall
establish a program under which the Director of the National Institutes
of Health shall support or conduct research on valvular heart disease,
and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Cardiovascular Advances in Research
and Opportunities Legacy Act''.
SEC. 2. GRANTS FOR VALVULAR HEART DISEASE RESEARCH.
Subpart 2 of part C of title IV of the Public Health Service Act
(42 U.S.C. 285b et seq.) is amended by inserting after section 424C (42
U.S.C. 285b-7c) the following:
``SEC. 424D. GRANTS FOR VALVULAR HEART DISEASE RESEARCH.
``(a) In General.--The Director of the National Institutes of
Health, in consultation with the Director of the Institute, shall
support or conduct research regarding valvular heart disease.
``(b) Support Guidelines.--The distribution of funding authorized
in subsection (a) may be used to pursue the following outcomes--
``(1) using precision medicine and advanced technological
imaging to generate data on individuals with valvular heart
disease;
``(2) identifying and developing a cohort of individuals
with valvular heart disease and available data;
``(3) corroborating data generated through clinical trials
to develop a prediction model to distinguish individuals at
high risk for sudden cardiac arrest or sudden cardiac death
from valvular heart disease; or
``(4) for other outcomes needed to acquire necessary data
on valvular heart disease.
``(c) Mitral Valve Prolapse Workshop.--Not later than one year
after the date of the enactment of this section, the Director of the
Institute shall convene a workshop composed of subject matter experts
and stakeholders to identify research needs and opportunities to
develop prescriptive guidelines for treatment of individuals with
mitral valve prolapse.
``(d) Authorization of Appropriations.--For the purpose of carrying
out this section, there is authorized to be appropriated $20,000,000
for each of fiscal years 2022 through 2026.''.
SEC. 3. PROGRAMS OF CENTERS FOR DISEASE CONTROL AND PREVENTION.
Part J of title III of the Public Health Service Act (42 U.S.C. 2
et seq.) is amended by inserting after section 393 the following
section:
``SEC. 393A. PREVENTION OF SUDDEN CARDIAC DEATH AS A RESULT OF VALVULAR
HEART DISEASE.
``(a) In General.--The Secretary, acting through the Director of
the Centers for Disease Control and Prevention, may carry out projects
to increase education, awareness or diagnosis of valvular heart disease
and to reduce the incidence of sudden cardiac death caused by valvular
heart disease. Such projects may be carried out by the Secretary
directly or through awards of grants or contracts to public or
nonprofit private entities. The Secretary may directly (or through such
awards) provide technical assistance with respect to the planning,
development, and operation of such projects.
``(b) Certain Activities.--Projects carried out under subsection
(a) may include--
``(1) the implementation of public information and
education programs for--
``(A) the prevention of sudden cardiac death from
valvular heart disease;
``(B) broadening the awareness of the public
concerning the risk factors for, the symptoms of, and
the public health consequences of valvular heart
disease; and
``(C) increasing screening, detection, and
diagnosis of valvular heart disease; and
``(2) surveillance of out of hospital cardiac arrests to
improve patient outcomes.
``(c) Grant Prioritization.--The Secretary may, in awarding grants
or entering into contracts pursuant to subsection (a), give priority to
entities seeking to carry out projects that target populations most
impacted by valvular heart disease.
``(d) Coordination of Activities.--The Secretary shall ensure that
activities under this section are coordinated, as appropriate, with
other agencies of the Public Health Service that carry out activities
regarding valvular heart disease.
``(e) Best Practices.--The Secretary, acting through the Director
of the Centers for Disease Control and Prevention, shall--
``(1) collect and analyze the findings of research
conducted with respect to valvular heart disease; and
``(2) taking into account such findings, publish on the
website of the Centers for Disease Control and Prevention best
practices for physicians and other health care providers who
provide care to individuals with valvular heart disease.
``(f) Authorization of Appropriations.--For the purpose of carrying
out this section, there is authorized to be appropriated such sums as
may be necessary for each of fiscal years 2022 through 2026.''.
<all>